Burt Wealth Advisors - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 24 filers reported holding VASCULAR BIOGENICS LTD in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Burt Wealth Advisors ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q4 2020$3,000
+50.0%
1,6740.0%0.00%0.0%
Q3 2020$2,0000.0%1,6740.0%0.00%0.0%
Q2 2020$2,0000.0%1,6740.0%0.00%0.0%
Q1 2020$2,0000.0%1,6740.0%0.00%0.0%
Q4 2019$2,0000.0%1,6740.0%0.00%0.0%
Q3 2019$2,0000.0%1,6740.0%0.00%0.0%
Q2 2019$2,000
-33.3%
1,6740.0%0.00%0.0%
Q1 2019$3,000
+50.0%
1,6740.0%0.00%0.0%
Q4 2018$2,000
-33.3%
1,6740.0%0.00%0.0%
Q3 2018$3,000
-25.0%
1,6740.0%0.00%
-50.0%
Q2 2018$4,0000.0%1,6740.0%0.00%0.0%
Q1 2018$4,000
-66.7%
1,6740.0%0.00%
-71.4%
Q4 2017$12,000
+20.0%
1,6740.0%0.01%0.0%
Q3 2017$10,000
+42.9%
1,6740.0%0.01%
+40.0%
Q2 2017$7,000
-22.2%
1,6740.0%0.01%
-16.7%
Q1 2017$9,000
+12.5%
1,6740.0%0.01%
-14.3%
Q4 2016$8,0000.0%1,6740.0%0.01%
-22.2%
Q3 2016$8,000
+14.3%
1,6740.0%0.01%
+12.5%
Q2 2016$7,000
+40.0%
1,6740.0%0.01%
+60.0%
Q1 2016$5,000
-58.3%
1,6740.0%0.01%
-50.0%
Q4 2015$12,0000.0%1,6740.0%0.01%
-33.3%
Q3 2015$12,000
+9.1%
1,6740.0%0.02%
+25.0%
Q2 2015$11,0001,6740.01%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q2 2016
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 152,764$365,0000.50%
Ikarian Capital, LLC 800,811$1,915,0000.16%
DAFNA Capital Management LLC 306,980$734,0000.15%
PVG ASSET MANAGEMENT CORP 12,155$29,050,0000.09%
Phoenix Holdings Ltd. 1,060,300$2,534,0000.05%
Virtu Financial LLC 39,618$95,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 89,689$214,0000.01%
HBK Sorce Advisory LLC 22,000$53,0000.00%
MORGAN STANLEY 693,420$1,658,0000.00%
Bank of New York Mellon Corp 25,000$60,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders